Entera Bio annual net debt
2017
2019
2020
2021
2022
2023
2024
2025
Entera Bio Net Debt Growth & History (ENTX)
Entera Bio's net debt was −$6.6M for fiscal 2025.
View full Entera Bio company overviewEntera Bio annual net debt history
| Fiscal year | Period ended | Net debt | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$6.6M | $1.8M | — |
| 2024 | 2024-12-31 | −$8.4M | $2.2M | — |
| 2023 | 2023-12-31 | −$10.6M | $1.6M | — |
| 2022 | 2022-12-31 | −$12.2M | $12.4M | — |
| 2021 | 2021-12-31 | −$24.6M | −$16.9M | — |
| 2020 | 2020-12-31 | −$7.7M | $7.2M | — |
| 2019 | 2019-12-31 | −$14.9M | — | — |
| 2017 | 2017-12-31 | −$7.9M | — | — |
Entera Bio quarterly net debt
Q4.19
Q2.20
Q4.20
Q2.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Net debt | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$10.9M | −$229,000 | — |
| Q1 2026 | 2026-03-31 | −$3.7M | $8.7M | — |
| Q4 2025 | 2025-12-31 | −$6.6M | $1.8M | — |
| Q3 2025 | 2025-09-30 | −$8.4M | −$1.8M | — |
| Q2 2025 | 2025-06-30 | −$10.7M | −$1.9M | — |
| Q1 2025 | 2025-03-31 | −$12.4M | −$3.5M | — |
| Q4 2024 | 2024-12-31 | −$8.4M | $2.2M | — |
| Q3 2024 | 2024-09-30 | −$6.6M | $577,000 | — |
| Q2 2024 | 2024-06-30 | −$8.7M | −$43,000 | — |
| Q1 2024 | 2024-03-31 | −$8.8M | $1.8M | — |
| Q4 2023 | 2023-12-31 | −$10.6M | $1.6M | — |
| Q3 2023 | 2023-09-30 | −$7.2M | $7.0M | — |
| Q2 2023 | 2023-06-30 | −$8.7M | $8.4M | — |
| Q1 2023 | 2023-03-31 | −$10.6M | $9.2M | — |
| Q4 2022 | 2022-12-31 | −$12.2M | $12.4M | — |
| Q3 2022 | 2022-09-30 | −$14.2M | — | — |
| Q2 2022 | 2022-06-30 | −$17.1M | $9.5M | — |
| Q1 2022 | 2022-03-31 | −$19.9M | — | — |
| Q4 2021 | 2021-12-31 | −$24.6M | −$16.9M | — |
| Q2 2021 | 2021-06-30 | −$26.6M | −$17.0M | — |
| Q4 2020 | 2020-12-31 | −$7.7M | $7.2M | — |
| Q2 2020 | 2020-06-30 | −$9.5M | — | — |
| Q4 2019 | 2019-12-31 | −$14.9M | — | — |
Entera Bio net debt trends
Over the last five fiscal years, Entera Bio's net debt increased from −$7.7M to −$6.6M, a change of $1.1M. The latest reported quarter, Q2 2026, shows −$10.9M.
About the metric
What net debt means
Net debt compares a company’s interest-bearing debt with its cash and cash equivalents. Positive net debt means debt exceeds cash, while a negative value indicates the company has more cash than debt on this measure.
Calculation and source
How net debt is calculated
TickerStat calculates net debt as total interest-bearing debt minus cash and cash equivalents at the same reporting-period end. Short-term investments are not subtracted because they are not included in the standardized cash series. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Entera Bio source filings ↗